Altcoins News

Story: Nasdaq Biotech Firm Windtree to Raise $200M for First-Ever BNB Crypto Treasury

By Maheen Hernandez

1 / 15

Windtree Therapeutics, a biotechnology company listed on the Nasdaq, is preparing to raise as much as $200 million to create a digital asset treasury based on BNB, the native…

2 / 15

Headquartered in Warrington, Pennsylvania, Windtree disclosed that it has already secured a securities purchase agreement worth $60 million with Build and Build Corp, a…

3 / 15

The funding will be used to gradually acquire BNB, positioning the token as a long-term asset on Windtree’s balance sheet.

4 / 15

BNB, originally created by Binance and now the core asset of the BNB Chain ecosystem, is currently the fifth-largest cryptocurrency by market capitalization.

5 / 15

Windtree’s decision follows a broader trend where corporations are exploring crypto assets not just as speculative tools but as long-term stores of value or means of…

6 / 15

Now, biotech and healthcare-adjacent firms appear to be at the forefront of this emerging trend.

7 / 15

The Strategy Behind Windtree’s BNB Treasury

8 / 15

While the crypto world has seen several companies embrace digital assets, few have done so as publicly and aggressively as Windtree is now attempting.

9 / 15

BNB’s utility across DeFi platforms, smart contracts, and tokenized assets makes it an attractive option for companies looking to future-proof their digital strategies.

10 / 15

The agreement with Build and Build Corp further solidifies Windtree’s crypto aspirations. This investor has a history of supporting Web3 infrastructure projects and could…

11 / 15

Market Reaction and Share Price Performance

12 / 15

Windtree’s stock responded positively to the news. On Wednesday, the company’s shares closed at $0.90, showing a gain of 8.62%.

13 / 15

This boost reflects investor optimism about the company’s forward-thinking strategy. While biotech stocks often react to clinical trial outcomes or regulatory Reveals, this…

14 / 15

Windtree’s decision could set a precedent for other biotech firms or publicly traded companies looking to allocate capital into digital assets.

15 / 15

This also speaks to a changing perception of BNB, which, despite its origin from a centralized exchange, is increasingly viewed as part of a broader decentralized network.

The Currency Analytics

Want the full story?